{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T23:19:44Z","timestamp":1769210384616,"version":"3.49.0"},"reference-count":34,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jom-2025-0107_abs_001\">\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>As systematic reviews and meta-analyses (SRMAs) are crucial for treatment development, they must provide guidelines that represent diverse patient demographics to promote equitable health care. As new research and treatment modalities are being developed for geographic atrophy (GA), establishing an equitable research foundation is becoming vitally important to physicians as they personalize their treatment plans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jom-2025-0107_abs_002\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This analysis aims to determine whether SRMAs pertaining to GA are reporting equity-related items utilizing the PROGRESS-Plus framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jom-2025-0107_abs_003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a cross-sectional analysis by searching databases for systematic reviews and meta-analyses concerning GA from the year 2000 to November 2023. From this search, 176 articles returned, but only 57 of them met all the inclusion criteria. After screening the articles for inclusion, data pertaining to PROGRESS-Plus items were extracted. All analyses were conducted in a masked and duplicative fashion.\u00a0\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u00a0tests were employed to determine whether associations existed between the variables.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jom-2025-0107_abs_004\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From the initial search, 176 articles returned, of which 119 were excluded due to duplication, data unrelated to GA, or because it was animal-based research. Of the remaining 57 studies, 26 (45.6\u202f%) included zero PROGRESS-Plus items. Fewer articles from the US-reported equity items (31.3\u202f%, 5\/16) compared to other countries (63.4\u202f%, 26\/41), which held statistical significance (p=0.028).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jom-2025-0107_abs_005\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The American Academy of Ophthalmology has created initiatives to increase diversity, equity, and inclusion within the subspecialty. By using the PROGRESS-Plus framework, this study concluded that the majority of the articles pertaining to GA do not meet equity item objectives. As these documents aid physicians in developing treatment plans, these findings are concerning as physicians may find it more difficult to individually tailor treatment plans according to each patient\u2019s holistic needs. Limitations in this study included unintentional omission or misclassification of research documents despite the comprehensive search string and double-blinded analysis. Furthermore, the results of this study cannot be generalized to other areas of research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jom-2025-0107","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T08:46:06Z","timestamp":1758098766000},"page":"79-85","source":"Crossref","is-referenced-by-count":0,"title":["Equity reporting in systematic reviews and meta-analysis for geographic atrophy: a PROGRESS-Plus assessment"],"prefix":"10.1515","volume":"126","author":[{"given":"Ryan","family":"Emmert","sequence":"first","affiliation":[{"name":"College of Osteopathic Medicine, Oklahoma State University , Tulsa , OK , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler","family":"McKenzie","sequence":"additional","affiliation":[{"name":"Office of Medical Student Research , College of Osteopathic Medicine at Cherokee Nation, Oklahoma State University , Tahlequah , OK , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawsyn","family":"Smith","sequence":"additional","affiliation":[{"name":"Office of Medical Student Research , College of Osteopathic Medicine at Cherokee Nation, Oklahoma State University , Tahlequah , OK , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Russell","sequence":"additional","affiliation":[{"name":"Office of Medical Student Research , College of Osteopathic Medicine at Cherokee Nation, Oklahoma State University , Tahlequah , OK , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gracie","family":"Schultheis","sequence":"additional","affiliation":[{"name":"Office of Medical Student Research , Oklahoma State University Center for Health Sciences , Tulsa , OK , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micah","family":"Hartwell","sequence":"additional","affiliation":[{"name":"Office of Medical Student Research , College of Osteopathic Medicine at Cherokee Nation, Oklahoma State University , Tahlequah , OK , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"2026012319181836255_j_jom-2025-0107_ref_001","doi-asserted-by":"crossref","unstructured":"Ambati, J, Ambati, BK, Yoo, SH, Ianchulev, S, Adamis, AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003;48:257.","DOI":"10.1016\/S0039-6257(03)00030-4"},{"key":"2026012319181836255_j_jom-2025-0107_ref_002","unstructured":"Center for Disease Control. VEHSS modeled estimates for age-related macular degeneration (AMD). Vision and Eye Health Surveillance System; 2023. https:\/\/www.cdc.gov\/vision-health-data\/prevalence-estimates\/amd-prevalence.html [Accessed 8 Oct 2023]."},{"key":"2026012319181836255_j_jom-2025-0107_ref_003","doi-asserted-by":"crossref","unstructured":"Fleckenstein, M, Mitchell, P, Freund, KB, Sadda, S, Holz, FG, Brittain, C, et al.. The progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology 2018;125:369. https:\/\/doi.org\/10.1016\/j.ophtha.2017.08.038.","DOI":"10.1016\/j.ophtha.2017.08.038"},{"key":"2026012319181836255_j_jom-2025-0107_ref_004","doi-asserted-by":"crossref","unstructured":"Marsiglia, M, Boddu, S, Bearelly, S, Xu, L, Breaux, BEJr., Freund, KB, et al.. Association between geographic atrophy progression and reticular pseudodrusen in eyes with dry age-related macular degeneration. Investig Ophthalmol Vis Sci 2013;54:7362. https:\/\/doi.org\/10.1167\/iovs.12-11073.","DOI":"10.1167\/iovs.12-11073"},{"key":"2026012319181836255_j_jom-2025-0107_ref_005","doi-asserted-by":"crossref","unstructured":"Shen, L, Liu, F, Grossetta Nardini, H, Del Priore, LV. Natural history of geographic atrophy in untreated eyes with nonexudative age-related macular degeneration: a systematic review and meta-analysis. Ophthalmol Retina 2018;2:914\u201321. https:\/\/doi.org\/10.1016\/j.oret.2018.01.019.","DOI":"10.1016\/j.oret.2018.01.019"},{"key":"2026012319181836255_j_jom-2025-0107_ref_006","doi-asserted-by":"crossref","unstructured":"Wightman, AJ, Guymer, RH. Reticular pseudodrusen: current understanding. Clin Exp Optom 2019;102:455. https:\/\/doi.org\/10.1111\/cxo.12842.","DOI":"10.1111\/cxo.12842"},{"key":"2026012319181836255_j_jom-2025-0107_ref_007","doi-asserted-by":"crossref","unstructured":"Keenan, TDL. Geographic atrophy in age-related macular degeneration: a tale of two stages. Ophthalmol Sci 2023;3:100306. https:\/\/doi.org\/10.1016\/j.xops.2023.100306.","DOI":"10.1016\/j.xops.2023.100306"},{"key":"2026012319181836255_j_jom-2025-0107_ref_008","unstructured":"Nielsen, MK, Shah, YS, Kim, LA, Koushik, T, Do, DV, Bhagat, N, et al.. Geographic Atrophy - EyeWiki. The American Academy of Ophthalmology. https:\/\/eyewiki.org\/Geographic_Atrophy [Accessed 9 Oct 2023]."},{"key":"2026012319181836255_j_jom-2025-0107_ref_009","doi-asserted-by":"crossref","unstructured":"Smith, W, Assink, J, Klein, R, Mitchell, P, Klaver, CC, Klein, BE, et al.. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001;108:697.","DOI":"10.1016\/S0161-6420(00)00580-7"},{"key":"2026012319181836255_j_jom-2025-0107_ref_010","doi-asserted-by":"crossref","unstructured":"Fraser-Bell, S, Donofrio, J, Wu, J, Klein, R, Azen, SP, Varma, R. Sociodemographic factors and age-related macular degeneration in Latinos: the Los Angeles Latino eye study. Am J Ophthalmol 2005;139:30. https:\/\/doi.org\/10.1016\/j.ajo.2004.08.029.","DOI":"10.1016\/j.ajo.2004.08.029"},{"key":"2026012319181836255_j_jom-2025-0107_ref_011","unstructured":"Elshatory, YM, Hypes, S, Caulk, G, Feldman, BH, Shah, VA, Kim, LA, et al.. Age-Related Macular Degeneration - EyeWiki. American Academy of Ophthalmology; 2023. https:\/\/eyewiki.org\/Age-Related_Macular_Degeneration [Accessed 9 Oct 2023]."},{"key":"2026012319181836255_j_jom-2025-0107_ref_012","unstructured":"Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration: a case-control study in the age-related eye disease study: age-related eye disease study report number 3. Ophthalmology 2000;107:2224\u201332."},{"key":"2026012319181836255_j_jom-2025-0107_ref_013","doi-asserted-by":"crossref","unstructured":"Chakravarthy, U, Augood, C, Bentham, GC, de Jong, PT, Rahu, M, Seland, J, et al.. Cigarette smoking and age-related macular degeneration in the EUREYE study. Ophthalmology 2007;114:1157\u201363. https:\/\/doi.org\/10.1016\/j.ophtha.2006.09.022.","DOI":"10.1016\/j.ophtha.2006.09.022"},{"key":"2026012319181836255_j_jom-2025-0107_ref_014","doi-asserted-by":"crossref","unstructured":"Agr\u00f3n, E, Mares, J, Chew, EY, Keenan, TDL, AREDS2 Research Group. Adherence to a mediterranean diet and geographic atrophy enlargement rate: age-related eye disease study 2 report 29. Ophthalmology Retina 2022;6:762\u201370. https:\/\/doi.org\/10.1016\/j.oret.2022.03.022.","DOI":"10.1016\/j.oret.2022.03.022"},{"key":"2026012319181836255_j_jom-2025-0107_ref_015","doi-asserted-by":"crossref","unstructured":"Rowan, S, Jiang, S, Chang, ML, Volkin, J, Cassalman, C, Smith, KM, et al.. A low glycemic diet protects disease-prone Nrf2-deficient mice against age-related macular degeneration. Free Radic Biol Med 2020;150:75. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.02.010.","DOI":"10.1016\/j.freeradbiomed.2020.02.010"},{"key":"2026012319181836255_j_jom-2025-0107_ref_016","doi-asserted-by":"crossref","unstructured":"Keenan, TDL, Agr\u00f3n, E, Keane, PA, Domalpally, A, Chew, EY, Age-Related Eye Disease Study Research Group; Age-Related Eye Disease Study 2 Research Group. Oral antioxidant and lutein\/zeaxanthin supplements slow geographic atrophy progression to the fovea in age-related macular degeneration. Ophthalmology 2025;132:14\u201329. https:\/\/doi.org\/10.1016\/j.ophtha.2024.07.014.","DOI":"10.1016\/j.ophtha.2024.07.014"},{"key":"2026012319181836255_j_jom-2025-0107_ref_017","doi-asserted-by":"crossref","unstructured":"McGuinness, MB, Le, J, Mitchell, P, Gopinath, B, Cerin, E, Saksens, NT, et al.. Physical activity and age-related macular degeneration: a systematic literature review and meta-analysis. Am J Ophthalmol 2017;180:29\u201338. https:\/\/doi.org\/10.1016\/j.ajo.2017.05.016.","DOI":"10.1016\/j.ajo.2017.05.016"},{"key":"2026012319181836255_j_jom-2025-0107_ref_018","doi-asserted-by":"crossref","unstructured":"Mauschitz, MM, Schmitz, MT, Verzijden, T, Schmid, M, Thee, EF, Colijn, JM, et al.. Physical activity, incidence, and progression of age-related macular degeneration: a multicohort study. Am J Ophthalmol 2022;236:99\u2013106. https:\/\/doi.org\/10.1016\/j.ajo.2021.10.008.","DOI":"10.1016\/j.ajo.2021.10.008"},{"key":"2026012319181836255_j_jom-2025-0107_ref_019","doi-asserted-by":"crossref","unstructured":"Vassilev, ZP, Ruig\u00f3mez, A, Soriano-Gabarr\u00f3, M, Garc\u00eda Rodr\u00edguez, LA. Diabetes, cardiovascular morbidity, and risk of age-related macular degeneration in a primary care population. Investig Ophthalmol Vis Sci 2015;56:1585\u201392. https:\/\/doi.org\/10.1167\/iovs.14-16271.","DOI":"10.1167\/iovs.14-16271"},{"key":"2026012319181836255_j_jom-2025-0107_ref_020","unstructured":"Taylor, R. Novel Therapies and New Biomarkers in Geographic Atrophy. American Academy of Ophthalmology; 2023. https:\/\/www.aao.org\/eyenet\/article\/novel-therapies-new-biomarkers-geographic-atrophy [Accessed 1 Oct 2023]."},{"key":"2026012319181836255_j_jom-2025-0107_ref_021","doi-asserted-by":"crossref","unstructured":"Gopalakrishnan, S, Ganeshkumar, P. Systematic reviews and meta-analysis: understanding the best evidence in primary healthcare. J\u00a0Fam Med Prim Care 2013;2:9. https:\/\/doi.org\/10.4103\/2249-4863.109934.","DOI":"10.4103\/2249-4863.109934"},{"key":"2026012319181836255_j_jom-2025-0107_ref_022","doi-asserted-by":"crossref","unstructured":"Fountain, TR, Lee, P, Parke, DWII. Why ophthalmologists should care about disparities in vision health. Ophthalmology 2022;129:1075\u20136. https:\/\/doi.org\/10.1016\/j.ophtha.2022.06.036.","DOI":"10.1016\/j.ophtha.2022.06.036"},{"key":"2026012319181836255_j_jom-2025-0107_ref_023","doi-asserted-by":"crossref","unstructured":"Elam, AR, Tseng, VL, Rodriguez, TM, Mike, EV, Warren, AK, Coleman, AL, et al.. Disparities in vision health and eye care. Ophthalmology 2022;129:e89\u2013113. https:\/\/doi.org\/10.1016\/j.ophtha.2022.07.010.","DOI":"10.1016\/j.ophtha.2022.06.029"},{"key":"2026012319181836255_j_jom-2025-0107_ref_024","doi-asserted-by":"crossref","unstructured":"Evans, T, Brown, H. Road traffic crashes: operationalizing equity in the context of health sector reform. Inj Control Saf Promot 2003;10:11\u201312. https:\/\/doi.org\/10.1076\/icsp.10.1.11.14117.","DOI":"10.1076\/icsp.10.1.11.14117"},{"key":"2026012319181836255_j_jom-2025-0107_ref_025","doi-asserted-by":"crossref","unstructured":"O\u2019Neill, J, Tabish, H, Welch, V, Petticrew, M, Pottie, K, Clarke, M, et al.. Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health. J\u00a0Clin Epidemiol 2014;67:56. https:\/\/doi.org\/10.1016\/j.jclinepi.2013.08.005.","DOI":"10.1016\/j.jclinepi.2013.08.005"},{"key":"2026012319181836255_j_jom-2025-0107_ref_026","unstructured":"PROGRESS-Plus. Cochrane methods equity. https:\/\/methods.cochrane.org\/equity\/projects\/evidence-equity\/progress-plus [Accessed 25 Oct 2023]."},{"key":"2026012319181836255_j_jom-2025-0107_ref_027","doi-asserted-by":"crossref","unstructured":"Murad, MH, Wang, Z. Guidelines for reporting meta-epidemiological methodology research. Evid Based Med 2017;22:139\u201342. https:\/\/doi.org\/10.1136\/ebmed-2017-110713.","DOI":"10.1136\/ebmed-2017-110713"},{"key":"2026012319181836255_j_jom-2025-0107_ref_028","unstructured":"Lee-Poy, M, Stewart, M, Ryan, BL, Brown, JB. Asking patients about their religious and spiritual beliefs. Can Fam Physician 2016;62:e555\u201361."},{"key":"2026012319181836255_j_jom-2025-0107_ref_029","doi-asserted-by":"crossref","unstructured":"Landers, E, Batioja, K, Nguyen, T, Hester, M, Pasha, J, Roberts, W, et al.. Equity reporting in systematic reviews of opioid treatment of chronic non-cancer pain with patient-reported outcomes. J\u00a0Pain Palliat Care Pharmacother 2023;37:52\u201362. https:\/\/doi.org\/10.1080\/15360288.2022.2154884.","DOI":"10.1080\/15360288.2022.2154884"},{"key":"2026012319181836255_j_jom-2025-0107_ref_030","doi-asserted-by":"crossref","unstructured":"Hartwell, M, Lin, V, Gatewood, A, Sajjadi, NB, Garrett, M, Reddy, AK, et al.. Health disparities, COVID-19, and maternal and childbirth outcomes: a meta-epidemiological study of equity reporting in systematic reviews. J\u00a0Matern Fetal Neonatal Med 2022;35:9622\u201330. https:\/\/doi.org\/10.1080\/14767058.2022.2049750.","DOI":"10.1080\/14767058.2022.2049750"},{"key":"2026012319181836255_j_jom-2025-0107_ref_031","doi-asserted-by":"crossref","unstructured":"Karran, EL, Cashin, AG, Barker, T, Boyd, MA, Chiarotto, A, Dewidar, O, et al.. Using PROGRESS-plus to identify current approaches to the collection and reporting of equity-relevant data: a scoping review. J\u00a0Clin Epidemiol 2023;163:70\u20138. https:\/\/doi.org\/10.1016\/j.jclinepi.2023.09.017.","DOI":"10.1016\/j.jclinepi.2023.09.017"},{"key":"2026012319181836255_j_jom-2025-0107_ref_032","doi-asserted-by":"crossref","unstructured":"Petkovic, J, Jull, J, Yoganathan, M, Dewidar, O, Baird, S, Grimshaw, JM, et al.. Reporting of health equity considerations in cluster and individually randomized trials. Trials 2020;21:308. https:\/\/doi.org\/10.1186\/s13063-020-4223-5.","DOI":"10.1186\/s13063-020-4223-5"},{"key":"2026012319181836255_j_jom-2025-0107_ref_033","doi-asserted-by":"crossref","unstructured":"Kunonga, TP, Hanratty, B, Bower, P, Craig, D. A systematic review finds a lack of consensus in methodological approaches in health inequality\/inequity focused reviews. J\u00a0Clin Epidemiol 2023;156:76\u201384. https:\/\/doi.org\/10.1016\/j.jclinepi.2023.02.013.","DOI":"10.1016\/j.jclinepi.2023.02.013"},{"key":"2026012319181836255_j_jom-2025-0107_ref_034","doi-asserted-by":"crossref","unstructured":"Clevenger, L, Rachitskaya, A. Identifying geographic atrophy. Curr Opin Ophthalmol 2023;34:195\u2013202. https:\/\/doi.org\/10.1097\/icu.0000000000000952.","DOI":"10.1097\/ICU.0000000000000952"}],"container-title":["Journal of Osteopathic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jom-2025-0107\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jom-2025-0107\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T19:18:38Z","timestamp":1769195918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jom-2025-0107\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1,26]]},"published-print":{"date-parts":[[2026,1,26]]}},"alternative-id":["10.1515\/jom-2025-0107"],"URL":"https:\/\/doi.org\/10.1515\/jom-2025-0107","relation":{},"ISSN":["2702-3648"],"issn-type":[{"value":"2702-3648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]}}}